HIV Medication Access Workgroup

This section has been created to share information about the HIV Medication Access Workgroup. This workgroup was a convened as a result of a budget proviso by the Legislature as presented on SB5092, section 118.6.a. 

---

HIV PDL Medication Parity Proviso

Office of the Governor

(6)(a) $20,000 of the general fund—state appropriation for fiscal year 2022 is provided solely for the Washington state LGBTQ commission, in collaboration with the health care authority, department of health, advocates for people living with HIV in Washington, consumers, and medical professionals with expertise in serving the medicaid population living with HIV, to consider and develop recommendations regarding:

(i) Access to HIV antiretroviral drugs on the medicaid drug formulary, including short- and long-term fiscal implications of eliminating current prior authorization and fail-first requirements; 

(ii) Impact of drug access on public health and the statewide goal of reducing HIV transmissions; and

(iii) Maximizing pharmaceutical drug rebates for HIV antiretroviral drugs.

 (b) The commission shall submit a brief report with recommendations to the appropriate committees of the legislature by November 1, 2021.

---

If you are part of one of the stakeholder groups mentioned in the proviso and are interested in participating of the meetings or staying updated on the progress of this project, please fill out this form

Please use the following link to access the meetings. 

 

https://ofm-wa-gov.zoom.us/j/82798515979?pwd=TzZKcEoxazZ4R2sycVpuVkNJcWFOdz09

Meeting ID: 827 9851 5979

Passcode: 173957

 

Meeting Materials 

First Meeting - August 23rd

- Meeting Agenda

- Meeting Notes 

- Blueprint of Report to Legislature (DRAFT - for public input)

- Video Recording of First Workgroup Meeting

 

Second Meeting - September 13th 

- Notice of Public Meeting

- Meeting Agenda

- Meeting Notes 

- Video Recording of Second Workgroup Meeting 

- Presentations:

HIV Medication Management 
HIV Medication Pharmaceutical Rebates 
HIV Drug Utilization Data: State Comparison 
HIV Therapies Relative Costs
HIV Drugs Cost Models 
Costs Assumptions Slide 

 

Third Meeting - October 4th

- Notice of Public Meeting 

- Meeting Agenda

- DRAFT: Blueprint of Final Report (for feedback from partners) 

- Provide Feedback to the Blueprint of Final Report here

- Video Recording of Third Workgroup Meeting 

Presentations:

- Summary of Research on Efficacy of Single vs. Multiple Pills Regimens 

 

Fourth Meeting - October 25th 

- Notice of Public Meeting 

- Meeting Agenda 

- UPDATED DRAFT: Blueprint of Final Report (for input from partners) 

 

Town Halls 

- Notice of Public Town Hall Conversation - September 20th 

- Agenda: Town Hall September 20th 

- Recording of Town Hall Conversation on September 20th 

- Notice of Public Town Hall Conversation - October 12th 

- Agenda: Town Hall October 12th 

- Recording of Town Hall Conversation on October 12th

- Notes from Town Hall Conversation on October 12th 

 

Written Public Comments

- Testimony to Oct 12 2021 public town hall

- NMAC WA Open Access HIV Letter

- Letter from a provider

- Letter to LGBTQ Commission

 

Supporting Documents 

- Operating Guidelines for Workgroup Meetings 

End AIDS Washington Report

- Facts, Issues, Conundrums 

- UPDATED Blueprint Draft for Workgroup Review 

Understanding the Medicaid Prescription Drug Rebate Program

The Medicaid Drug Rebate Program and the impact of “best price” rules 

Payers’ Experiences with Confidential Pharmaceutical Price Discounts: A Survey of Public and Statutory Health Systems in North America, Europe, and Australasia

Drug Policy 101: Pharmaceutical Marketing Tactics

 - 2015 HIV Related Disparities from Department of Health

"Leveraging the Ryan White Program to Make Rapid Start of HIV Therapy Standard Practice" by the O'Neill Institute for National and Global Health Law

Washington State HIV Surveillance Report: 2020 edition

Other Resources

MAX Clinics in WA

- The MAX Clinic in King County - Addressing the needs of patients with complex medical and social needs

The Max Clinic: Medical Care Designed to Engage the Hardest-to-Reach Persons Living with HIV in Seattle and King County, Washington

HIV Care for Patients With Complex Needs: A Controlled Evaluation of a Walk-In, Incentivized Care Model

 

Models of Care and Health Management 

- Medicaid Self-Directed Services 

 

Research on HIV/AIDS and Mental Health 

- National Institute of Mental Health (NIMH): HIV/AIDS and Mental Health 

The Impact of Mental Health Across the HIV Care Continuum

HIV and Psychiatric Comorbidities: What Do We Know and What Can We Do?

 

Research on Single vs. Multiple Pills Regimens 

Study on effectiveness of single vs. multiple pills regimen (2021): Effectiveness and tolerability of dolutegravir and abacavir/lamivudine administered as two separate pills compared to their equivalent single-tablet regimen in a multicentre cohort in Spain